Scupltra

Sculptra is an injectable product used in the skin and underlying tissues. Sculptra is designed to help correct skin depressions, such as creases, wrinkles, folds, scars, hollow eye rings, degenerative skin aging, and facial lipoatrophy (loss of fat). Sculptra is a poly-L-lactic acid implant in the form of a sterile apyrogenic suspension. Poly-L-lactic acid is a biocompatible (does not harm the body), biodegradable (broken down or metabolized by the body), synthetic polymer from the alphahydroxyacid family (fruit acids). Poly-L-lactic acid has been used medically for many years in dissolvable stitches, and does not require pre-treatment skin testing for allergies.

Sculptra is approved by the United States Food and Drug Administration (FDA) for the restoration and/or correction of facial fat loss (lipoatrophy) in people with HIV. Sculptra has not been specifically approved by the FDA for aesthetic (cosmetic) use. Use of this product is considered “off-label” and is thereby used at the discretion and judgment allowed by the FDA to physicians. Sculptra has been used since 1999 in more than 150,000 patients in more than 30 countries, principally for cosmetic use.

Depending on the area treated, skin type and the injection technique, the effect of a treatment with these filler products can last 18 months or even longer, but that in some cases the duration of the effect can be shorter or even longer. Touch-up and follow-up treatments help sustain the desired degree of correction.